Table 3.
Patients’ RR
KRAS WT | N (%) |
---|---|
CR | 1 (2) |
PR | 12 (24) |
SD | 15 (30) |
PD | 22 (44) |
DCR | 28 (56) |
PFS (months) | 4.4 |
OS (months) | 10.4 |
CR, complete response; DCR, disease control rate; OS, overall survival; PD, progression disease; PFS, progression-free survival; PR, partial response; RR, response rate; SD, stable disease; WT, wild type.